Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for Extra-Strength 40U Formulation of JeuveauBusiness Wire • 16 days ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the Aesthetic Surgery Journal has published the...
Share to Feed
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an...
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $13.76, but opened at $13.36. Evolus shares last traded at...
This is a signal that EOLS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will present at the following investor...
This is a signal that EOLS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Evolus, Inc. (NASDAQ:EOLS Get Free Report) CFO Sandra Beaver sold 5,672 shares of Evolus stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $13.92...
Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028...
This indicator may be signaling that EOLS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Evolus prices stock offering to raise about $50M...